Release Summary

Researchers to Present Data Identifying Important Characteristics of Patients with PNH and aHUS and Data Supporting the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting.

Alexion Pharmaceuticals, Inc.